The Qualified Person needs to keep up-to-date with the latest changes in a ‘new pharmaceutical world’ with increasingly complex manufacturing and supply chains. Industry speakers describe what the QP needs to know and how they need to prepare to compliantly supply products. As the deadline for FMD Delegated Regulation for Safety Features approaches, this symposium covers the challenges of serialisation and product traceability. Our session on becoming a QP considers how QPs move into new areas of expertise, especially making a transition into working with Advanced Therapy Medicinal Products.
This is a fantastic opportunity to stay up to date with the issues and changes, network with fellow QPs and discuss the issues you face on a day-to-day basis.
Who should attend?
The event is aimed at:
- Find out about the latest regulatory and legislative changes including practical experience with Annex 16 and preparing for the serialisation deadline to meet the Falsified Medicines Directive
- Network with colleagues and sponsors and form valuable partnerships
- Discuss experiences with delegates and join in with the interactive panel discussions and Q&As
- Hear from the regulator and industry experts, including speakers from the Medicines and Healthcare products Regulatory Agency.
- The GMDP inspectorate will prove the latest news from an MHRA perspective. You will also hear from the MHRA's enforcement group about their work to combat the illegal trading of controlled drugs.
- Discuss experiences with delegates and join in with the interactive panel discussions and Q&As
- Visit the QP trainee and sponsor ‘information point’ to find out more about becoming a QP
This is a fantastic opportunity to stay up to date with the issues and changes, network with fellow QPs and discuss the issues you face on a day-to-day basis.
Who should attend?
The event is aimed at:
- Qualified Persons
- Individuals involved in assuring the quality of medicines
- Persons training to become a Qualified Person
- NHS and pharmaceutical industry
